Medication

International HIV Conference Reveals Exciting Progress in Global HIV Fight

French AIDS ambassador Michèle Boccoz, executive director of UNAIDS Michel Sidibé, mayor of Paris Anne Hidalgo and Christine Kafando, a community health worker from Burkina Faso, speak at a press conference on the new 90-90-90 UNAIDS report.Benjamin Ryan Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris. […]

Long-Acting Injectable HIV Treatment Moves Closer to Reality

By Warren Tong From TheBody.com Interesting reading from TheBody.com about long-acting injectable HIV treatment. Long-acting injectable treatment takes another step closer to becoming a real-world option for people living with HIV. The latest 96-week data from the LATTE-2 study, which is investigating long-acting injectable maintenance therapy for people with HIV, were presented at the 2017 International Conference on […]

Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300 mg)

Triumeq a new single tablet regimen (STR), combining abacavir 600mg, dolutegravir 50mg and lamivudine 300 mg has been approved by the Therapeutic Goods Administration (TGA) in Australia. It is manufactured by ViiV Healthcare and is already available in the US (Aug 2014) and European Union (Sept 2014). It is the first single-tablet regime that does […]